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1. Introduction 
Sex steroids are hormones produced mainly by the reproductive glands, either the ovaries 
or testes, which share a similar basic structure of three hexane rings and a pentane ring. 
They include estrogens, androgens, and progestogens, and each has major effects on 
reproductive physiology (Henderson, 2009; Osterlund & Hurd, 2001). Estrogens are 
required for normal female sexual maturation; they promote growth and differentiation of 
the breast, uterus, fallopian tubes, vagina, and ovaries (Carr, 1998). Male reproductive 
tissues, such as testis and prostate, are also estrogen target tissues (Clark et al., 1992). In 
addition, estrogens have an important role in bone maintenance (Turner et al., 1994), and 
protection of the cardiovascular system (Farhat et al., 1996) . 
Even though estrogens (e.g., 17┚-estradiol) and progestogens (e.g., progesterone) are 
classified as female sex hormones and androgens (e.g., testosterone) as male sex hormones, 
this categorization is misleading. In fact, for example, estrogens are found both in men and 
women, and they have effects in both sexes; besides, they arise in tissues other than the 
ovaries (Osterlund & Hurd, 2001).  
Among the sex steroids, estrogens are the best studied with respect to human non-
reproductive behaviors. They exert a broad range of effects throughout the body, including the 
central nervous system (CNS), where their actions are not limited to the regulation of 
reproductive neuroendocrinology and sexual behavior (Henderson 2009, 2010, 2011; Ziegler & 
Gallagher, 2005). In fact, accumulating evidence points to their involvement in influencing the 
function of numerous neural systems and, presumably, different behavioral domains 
(McEwen & Alves, 1999; McEwen et al, 2001; McEwen, 2010; Ziegler & Gallagher, 2005). 
Recent studies have highlighted a number of important, global issues regarding the influence 
of estrogen on cognitive functions (Lacreuse, 2006; Luine, 2007, 2008; Markou et al., 2007). 
A possible explanation for this effect can be represented by the modulator role exerted by 
estrogens on several neurotransmitter systems (such as acetylcholine, catecholamines, 
serotonin, and GABA), both in animals and humans (Amin et al, 2006; Dumas  et al 2006). 
Another reason may lie in the widespread presence of estrogen receptors (ERs) in many 
regions involved in cognitive processes, such as learning and memory, including the 
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hippocampal formation (HF), amygdala, and  cerebral cortex  (Genazzani et al 2007; 
Sherwin, 2003; Shughrue & Merchenthaler, 2000) . 
Sex-related differences in cognitive abilities, such as verbal, memory and spatial tasks, have 
been reported; in addition, several estrogen effects differ qualitatively or quantitatively 
between the sexes, suggesting that they could be subject to sexual differentiation during pre- 
or early postnatal development (Gasbarri et al, 2009). Ovarian hormones affect cognition 
and neural substrates subserving learning and memory functions, in both rodents (Daniel, 
2006; Warren & Juraska, 1997) and humans (Janowski  et al, 2000), as it was evidenced by 
studies assessing performances across the estrous and menstrual cycles. Sex-related 
differences in brain function are also observed in the incidence of some psychopathology, 
such as depressive illness, which is more frequent in women, antisocial behavior and 
substance abuse, which are more common in men (McEwen, 2002). The variety of these 
effects confirms that other brain structures are implicated, besides the hypothalamus, which 
has been the traditional site for the study of ovarian steroid receptors and their role in the 
control of reproductive function. For example, the hormonal influences on motor activity 
involve brain areas such as the nucleus accumbens, striatum, substantia nigra and ventral 
tegmental area, while the effects on memory processes imply actions on brain structures 
such as basal forebrain and HF, and those on mood involve, at least in part, the serotonergic 
system of the midbrain raphe nuclei.  
Postmenopausal alterations of the limbic system are related to mood changes, anxiety, 
depression, insomnia, headaches/migraine, alterations of cognitive functions (Genazzani et 
al 2002).  
Even though there is currently a substantial literature on the putative neuroprotective 
effects of estrogen on cognitive functions  in postmenopausal women, some discrepancy still 
exists. The critical period hypothesis, validated several years ago, attempts to account for 
the literature inconsistencies by positing that estrogen treatment  can  protect aspects of 
cognition in older women only if treatment starts soon after the menopause. Although it is 
not totally clear why estrogen administered to women over 65 does not provide any 
neuroprotection and may even impair cognition, it could be possible that the events 
characterizing brain aging (such as alterations in neurotransmitter systems and decrease of 
brain volume, neuronal size, dendritic spine number) represent an adverse background 
preventing the neuroprotective effect of exogenous estrogen on the brain. Other factors that 
could have contributed to the discrepancies in the literature include differences in the type 
of estrogen compounds used, their route of administration, cyclic versus continuous 
regimens, and the concomitant administration of progestins (Sherwin & Henry, 2008). 
2. Neurobiology of estrogen  
The identification and mapping of ERs in the brain led to the discovery that they are 
concentrated in the hypothalamus, hypophysis, HF, cerebral cortex, midbrain, and 
brainstem (Micevych & Mermelstein, 2008). 
Even though a complete description is beyond the scope of the present paper, the 
mechanisms that are likely the most relevant to explain the cognitive function of estrogen 
are briefly described here (see McEwen, 2002, for a review). 
The nuclear ERs are ligands activated transcription factors belonging to the steroid hormone 
receptors, included in the nuclear receptor superfamily (Osterlund & Hurd, 2001).  Two 
types of ERs are known: ER┙ and ER┚, which are similar in their structural organization into 
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domains, but differ in their binding affinities for diverse ligands and selective ER 
modulators (Gruber et al, 2002; Rehman & Masson, 2005). 
ER┙ and ER┚ are products of different genes and show tissue- and cell-type specific 
expression (Pettersson & Gustafsson, 2001). Both ERs are widely distributed throughout the 
body (Rehman & Masson, 2005) and have also been localized in several cerebral areas, such 
as the cortex, amygdala, HF, basal forebrain, cerebellum, locus coeruleus, rafe, and central 
grey matter, confirming an involvement of estrogen in controlling cognitive functions in 
both physiological and pathological conditions (Sherwin, 1997; Sherwin & Henry, 2008).  
The cerebral distribution of ER┙ has been quite well established by steroid autoradiography, 
immunocytochemistry, and in situ hybridization (Pfaff, 1980) and many studies have shown 
nuclear and extranuclear ER┚ immunoreactivity in several brain regions, especially the 
hippocampus (Milner et al, 2005; Mitra et al, 2003). The ER┙ mRNA expression prevail in 
the hypothalamus and amygdaloid complex, suggesting that the ┙-subtype could modulate 
neuronal populations involved in autonomic and reproductive neuroendocrine functions, as 
well as emotional processes. On the contrary, in the thalamus, HF, entorhinal cortex, and 
neocortex there is a prevalence of  ER┚, indicating a putative role for ER┚  in cognition, non-
emotional memory and motor functions (Osterlund & Hurd, 2001) The co-localization of 
ER┚ mRNA with cell nuclear ER┚  immunoreactivity was revealed in the cerebral cortex, 
paraventricular nuclei, and preoptic area of hypothalamus, in the rat (Shughrue & 
Merchenthaler, 2001)  It is important to note that the use of I 125 estrogen, which labels ERs 
with a higher specific radioactivity compared to  3H estradiol, allowed the detection of label 
in pyramidal cells of ventral hippocampal CAl and CA3 fields (Shughrue & Merchenthaler, 
2000), which are involved in memory processes. Besides its influence on both direct genomic 
actions, estrogen can also act in the CNS via nonnuclear receptors that implicate interactions 
of ERs with second messenger systems (Lee & McEwen, 2001; Sherwin & Henry, 2008) 
Concerning the subcellular localization of ER, in addition to the nuclear ERs, there is a 
predominant localization of ERs in proximity to the plasmatic  membrane of neuritis, soma, 
dendritic spines, and axon terminals (Clarke et al, 2000; McEwen et al, 2001). These results 
also imply  that classical ERs may have an intracellular dynamic action and suggest that ERs 
can be found in different subcellular structures. This is supported by findings showing that 
estrogen binds and interacts with proteins in the mitochondrial membranes and that ERs are 
associated with pre-synaptic structures, thus controlling synaptic transmission (Genazzani 
et al, 2007; Ledoux & Woolley, 2005). In conclusion, estrogen effects on the brain include 
complex cellular mechanisms ranging from classical nuclear to non-classical membrane-
mediated actions. Both forms of cell signaling could be activated separately, even though 
there is  evidence that they are intertwined at several cellular instances and can influence 
each other reciprocally, yielding synergic effects (Genazzani et al, 2007). 
Due to the widespread presence of the ERs in their different forms throughout the brain, 
estrogen actions are also widespread and affect many neurotransmitter systems including 
the cholinergic, catecholaminergic, serotonergic, and GABAergic systems (McEwen, 2002). 
The influence of estrogen on cerebral structures and functions offer possible explanations for 
the mechanisms of action by which this steroid hormone could affect cognitive functions in 
women. For example, it was reported that one of the effects of estrogen is to enhance the 
density of dendritic spine on CAl hippocampal neurons within 24–72 h after its acute 
administration (Woolley et al, 1990). Moreover, estrogens increase the concentration of 
choline acetyltransferase (ChAT), critically involved in memory functions and whose levels 
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are markedly decreased in Alzheimer’s disease (AD) (Gibbs & Aggarwal, 1998). The 
neuroprotective action of estrogen could also be exerted through a modulator effect on 
molecules involved in apoptosis (Pike, 1999) and  its antioxidant action. The potential for the 
numerous mechanisms of action of estrogen to affect the structure and function of cerebral 
areas that subserve several cognitive functions provides biological plausibility for the 
hypothesis that estrogen could protect cognitive functions  in aging women. 
3. Estrogen and cognition   
The term cognition indicates the totality of human information processing, including 
psychomotor skills, pattern recognition, attention, language, learning and memory, problem 
solving, abstract reasoning or higher-order intellectual functioning. 
In female mammals, including rodents and non-human primates, estrogen effects on non-
reproductive behaviors include, besides anxiety and depressive-like behaviors,  cognitive 
behaviors (Spencer et al, 2008; Walf & Frye, 2006) When administered to ovariectomized 
(OVX) rats, estradiol decreases anxiety and depressant behavior in laboratory tests (Walf & 
Frye, 2006). The effects of estrogen on cognition depend on the type of task performed and 
on the brain regions involved. For instance, while estradiol impairs performance on 
striatum-dependent tasks in female rats (Davis et al, 2005; Korol, 2004) it improves 
performance on prefrontal cortical-dependent learning in female rats (Luine, 2008) rhesus 
monkeys (Hao et al, 2007; Rapp et al, 2003) and both young adult and post-menopausal 
women (Berman, 1997) . It also enhances performance on HF-dependent tasks in female 
mice (Li et al, 2004; Xu & Zhang, 2006) , rats (Daniel et al, 1997; Sandstrom & Williams, 2004)  
and rhesus monkeys (Lacreuse et al, 2002; Rapp et al, 2003). Findings showing improved 
performance after estradiol infusion directly into the HF, but not other cerebral areas 
(Zurkovsky et al, 2006), provides behavioral evidence that the estradiol enhancement of HF-
dependent tasks indeed represents a specific effect on HF function. However, estrogen’s 
roles on cognitive function may result from the sum of interacting influences on numerous 
cerebral regions, including striatum, HF, basal forebrain, and prefrontal cortex (PFC).  
3.1 Estrogen in learning and memory   
Signaling pathways and gene expression regulated by estrogen include activation of CREB, 
GABA-A receptors, NMDA receptors, glutamic acid decarboxylase (GAD), ChAT, and 
synaptic and spine-associated proteins (Frick et al, 2002; McEwen et al, 2001; Rudick & 
Woolley , 2003).  
Studies in knockout mice using the selective estrogen receptor modulators suggest that ER┙ 
and ER┚ contribute differently to memory mechanisms (Rhodes & Frye, 2006; Rissman et al, 
2002). Several studies  have shown estrogen regulation of ER┙ (Hart et al, 2001; 2007)  
Moreover, it was reported that selective ER┚ agonists increased levels of key synaptic 
proteins in vivo in the HF, and these effects were absent in ER┚ knockout mice or after 
treatment with an ER┙ agonist. ER┚ agonists also induced morphological changes in HF 
neurons, such as an enhanced density of mushroom-type spines. Most importantly, estrogen 
or ER┚ agonists improved performance in some HF-dependent memory tasks (Liu et al, 
2008). Therefore, these results confirm the role of ER┚ in memory, but cross-talk between 
ER┙ and ER┚ receptors cannot be excluded. 
It was also evidenced that rapid improvements in cognition could be mediated by 
membrane associated estrogen receptors activating mitogen-activated protein kinase 
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(MAPK) signalling pathways in specific neural sites (Bryant et al, 2006). For example, 
estrogen enhances performance in tasks such as inhibitory avoidance (IA), object recognition 
and placement within 4h of treatment; a post-training paradigm evidenced that these effects 
are due to the facilitatory action of estrogen on memory (Frye et al, 2007; Luine, 2008; 
Rhodes & Frye, 2006; Walf & Frye, 2006). Previous memory studies  hypothesized that 
newly-acquired informations are transferred to long-term memory over time, and seminal 
work by McGaugh and co-workers has shown that consolidation takes place within 1–2 h 
post-training (McGaugh, 2000). In addition, the impairment or improvement of the 
consolidation process due to drugs or hormones can occur if they are given within this time, 
but not later. Estrogen-related enhancement of consolidation utilizing post-training 
paradigms have been shown in some memory tasks, such as Morris water maze (MWM), IA, 
object recognition and object placement (Frye et al, 2007; Luine et al, 2008; Rhodes & Frye, 
2006; Walf & Frye, 2006). Administration of the powerful estrogen agonist, diethylstilbestrol, 
either immediately before or immediately after the presentation of  objects, increased  
discrimination between previously viewed and never viewed items in the recognition trial. 
Therefore, temporal relations between hormonal application and performance 
enhancements are in agreement with memory improvement.  
Estrogen not only modulates memory formation and maintenance processes in some 
contexts, but also biases the learning strategy utilized to solve a task, thus changing what 
and how information is learned, and therefore not only how much is learned, i.e., the 
strength of the memory (Gasbarri et al, 2009, Pompili et al, 2010). 
Rats with high estrogen levels utilize place or allocentric strategies rather successfully, 
outperforming hormone-deprived rats on tasks requiring the configuration and use of 
extramaze cues for successful completion. On the contrary, rats with low estrogen levels 
tend to use response or egocentric strategies on tasks where the use of a directional turn, 
e.g., left or right, is required for acquisition (Korol, 2004). Taking into account the actions of 
estrogen across a large range of neural systems,  its modulation on cognition could be 
exerted by altering the relative involvement of specific memory systems, acting much like a 
conductor, orchestrating the dynamics, timing and coordination of multiple cognitive 
strategies during learning (McGaugh, 2000) . Influences on neurotransmitters, such as 
acetylcholine (ACh), regulating other processes, like inhibitory tone and excitability, reflect 
one of the mechanisms by which estrogen may orchestrate learning and memory. In fact, the 
ACh system is also activated by estrogen in cerebral areas that are important for memory, 
such as the basal forebrain and its ACh-containing projections to the HF and frontal cortex 
(Gibbs et al, 2004; Luine, 2008). 
Even though gonadal hormones influence cognition, these hormone-induced changes are 
not large (Luine, 2008), and they are reported especially when function is compromised by 
aging or lesions (Gulinello et al, 2006; Scharfman et al, 2007) however, they do not improve 
all the different aspects of cognition such as, for example, acquisition during memory 
processes (Dohanich, 2002; Luine, 2007). 
Rodents have been evaluated in different tasks, utilizing several kinds of mazes, and they 
rely on diverse reinforcements or contingencies (positive food rewards or aversive electric 
shocks) for the learning phase, and the tasks measure different kinds of memory, such as 
spatial memory, which requires the establishment of relationships between distant cues in 
the environment and the reinforcement site (Gasbarri et al, 2009). Other tasks use visual 
memory, based on visual associations. Nonetheless, many studies show positive effects of 
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estradiol on cognition (Dohanich, 2002) . Spatial memory, which is dependent on the HF, 
has been extensively evaluated using the radial arm maze (RM) and  MWM; studies 
conducted in OVX subjects show enhancements in performance during the acquisition 
(Dohanich, 2002; Luine et al. 1998) but, after learning how to solve the task (reference 
memory), estradiol no longer enhances performance (Fader et al, 1999; Luine et al. 1998) and 
could even impair spatial memory, although the data are not conclusive (Dohanichn 2002). 
Consistent estrogen-related improvements are reported in studies utilizing spatial tasks for 
the evaluation of working memory (WM) (Daniel & Dohanich, 2001; Luine, 2008; Sandstrom 
& Williams, 2001, 2004; Scharfman et al, 2007) defined as the ability to retain information in 
the face of potentially interfering distraction, in order to guide behavior and make a 
response (Baddeley, 1992, 1998).  
Results of studies, assessing hormonal effects on learning and memory, evidence the 
importance  that context and ⁄ or experience can have on performance, and these 
considerations may account, at least in part, for some inconsistency in the literature. 
Therefore, it is hypothesized that stress experienced during task performance may interfere 
with estrogen enhancements of some spatial tasks (Englemann et al, 2006; Frick et al, 2004). 
In addition, extensive handling, housing conditions, or environmental enrichment can also 
mitigate hormonal effects on other spatial tasks (Gresack  et al, 2007; Rubinow, et al 2004) 
Taking into account that cognition represents a complex, multidimensional set of higher-
order functions that are sub-served by specific, yet inter-related, cerebral areas, the 
intervention of other stimuli on the effects of estrogen is not unexpected. It is interesting to 
note that more recent research, evidencing consistent estrogen-related improvements of 
memory, use tasks evaluating working or short-term memory, tap into higher order 
memory or executive function, and also rely on cortical integration with HF fields 
(Ennaceur, et al 1997; Mumby et al, 2002). In addition, subjects are not exposed to stressful 
circumstances or negative reinforcers during the task. Therefore, recognition memory tests, 
where subjects have to discriminate between familiar and unfamiliar objects or objects in 
familiar or unfamiliar locations, appear to be quite consistently improved by estrogen and 
its agonists in OVX rats ( Luine, 2008) or mice (Fernandez & Frick, 2004; Li et al, 2004). 
In agreement with OVX models, pro-estrous rats evidenced better recognition memory 
compared to rats in a different phase of the estrous cycle (Frye et al 2007; Walf & Frye, 2006) 
and mice show better spatial memory in pro-estrous (Frick et al, 2001). However, rats in pro-
estrous phase are often impaired during acquisition (Bowman et al, 2001; Frye, 1995; Warren 
& Juraska, 1997). Other researchers did not show modifications over the cycle (Berry et al, 
1997;  Stackman et al, 1997) this inconsistency could be explaining taking into account that 
they evaluated reference memory, which seems to be insensitive to hormones after 
acquisition. 
3.1.1 Estrogen and working memory 
As evidenced by research assessing performances across the estrous and menstrual cycles,  
ovarian hormones affect cognition and neural substrates subserving learning and memory, 
including WM, in both rodents (Craig &Murphy , 2007; Daniel, 2006; Warren & Juraska, 
1997) and humans (Bimonte & Denenberg, 1999; Janowski et al, 2000). The decrease of 
estrogen following ovariectomy or menopause enhances the risk of diseases, such as 
osteoporosis and vasomotor dysfunction (Timins, 2004; Warren & Halpert, 2004), but could 
also be involved in the development of cognitive impairments (Markou, 2007; Sherwin, 
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2003). ERT relieves several menopausal symptoms, but whether its benefits include 
protection of cognitive functions is still controversial (LeBlanc  et al, 2007; Tivis et al, 2001). 
In recent years, considerable progress has been made towards specifying the neural 
mechanisms underlying WM in humans (Baddeley, 1998; Repovs & Baddeley , 2006). 
Data from OVX rats treated with estrogen, compared to OVX untreated controls, showed 
improvements in performance of some tasks, including those require spatial WM, such as 
the RM (Daniel et al, 1997; Fader et al, 1999) and a 2-choice WM task (O'Neal et al, 1996) and 
impairments in spatial reference memory tests, such as the MWM (Warren & Juraska, 1997). 
Estrogen replacement therapy (ERT) enhances spatial WM performance both on MWM and 
RM (Bimonte & Denenberg, 1999; Fader et al, 1999), confirming previous evidence that 
estrogen selectively improves performance on tasks depending on WM (Daniel et al, 1997; 
O'Neal et al, 1996). In fact, estrogen treatment improved WM performance during maze 
acquisition, without affecting reference memory performance; scopolamine treatment 
impaired WM, but not reference memory, while estrogen prevented the impairment of WM 
by scopolamine. A recent paper reported substantial sex differences in the effects of 
gonadectomy and hormone replacement on spatial working and reference memory in male 
and female rats (Gibbs & Jognson, 2008). An interesting direction of this field is the idea that 
estrogens may influence learning strategy, independent from memory. 
Furthermore, ERT in both physiologically low and moderate doses improved the capability 
of ovariectomized rats to handle increasing amounts of WM information, when the demand 
on an animal’s WM system was restricted to one to four elements of information (Bimonte & 
Denenberg, 1999). However, when the demand on the WM system was increased to six 
elements of information, ERT in physiologically moderate doses provided the maximum 
benefit, even beyond that of intact females.  
Moreover, it was reported that estrogen can prevent deficits in spatial WM induced by 
neurotoxin treatments aimed to mimic the pathology of early AD (Hruska & Dohanich, 2007). 
Cholinergic and HF systems are closely related to learning and memory processes 
(Hasselmo, 2006), and it can be predicted that estrogen has its most profound effect on HF-
dependent cognitive functions such as learning and memory. In fact, estrogen enhances 
ACh function and the synthesis of ACh in basal forebrain and the Ach neurons projecting to 
the HF and cortex (Hasselmo, 2006), (Singh et al, 1994), and mediates dendritic spine density 
in the hippocampal CA1 region (Li et al, 2004; Wallace et al, 2007). The HF and adjacent 
anatomically related cortex play a crucial role in the explicit encoding and consolidation of 
verbal and nonverbal information into short-term memory, in humans (Squire, 2004). It has 
been speculated that estrogen activity in HF might underlie the effects of ERT on memory in 
postmenopausal women (Maki & Resnick, 2000; Maki, 2005). Estrogen receptors, as well as 
estradiol-concentrating neurons, were detected in the HF and entorhinal cortex of rodents 
(Prange-Kiel & Rune, 2006). Circulating estrogens have quantifiable effects on 
neurotransmitter activities in HF where, for example, a low estrogen state increases 
serotonin (5-HT) transporter activity in the HF, despite an apparent reduction in 5-HT 
transporter density (Bertrand, 2005); moreover, a regulation of NMDA and GABA receptors  
has also been reported (Jelks, 2007; Rudick & Woolley, 2001)  Estradiol administration in 
OVX rats produces increased ChAT activity and high-affinity choline uptake in CA1 field 
(Singh et al, 1994). Even though research has mainly focused on the medial temporal lobe 
areas, they do not represent the only neuroanatomical regions involved in human memory. 
In fact, the PFC mediates a number of cognitive processes contributing to memory function, 
particularly WM which is strongly related to the PFC in both humans and nonhuman 
www.intechopen.com
 
Sex Steroids 
 
170 
primates. In humans, WM represents the basis for many cognitive functions, including 
reasoning, reading comprehension, and mental calculations (Baddeley, 1998). Both non 
verbal (Owen et al, 1996) and verbal (Petrides  et al, 1993);  stimuli were utilized in 
experimental tasks with a relevant WM component. The important role of the PFC in WM 
was demonstrated after lesion and electrophysiological techniques in monkeys (Funahashi 
et al, 1993; Petrides, 1995) functional neuroimaging techniques in healthy human volunteers 
(Jonides et al, 1993; Owen et al, 1996); and localized cortical excisions in human neurological 
patients (Owen et al, 1995). Taking into consideration that, by definition, WM tasks 
intrinsically involve both temporary retention of verbal or visual information and its active 
manipulation, some research have clarified that the requirement for active manipulation 
during WM tasks specifically recruits activity in dorsolateral PFC  (Owen et al, 1995; 
Petrides, 1995; Postle et al, 1999). By contrast, passive storage processes seem to depend on 
more posterior brain areas, as evidenced by deficits in the immediate span for spatial or 
verbal information, in patients with lesion of parietal or perisylvian cortex (Milner, 1971) 
and by changes in functional cerebral activity in parietal and temporal regions of healthy 
volunteers, during performance of neuroimaging tasks that emphasize passive storage of 
information (Postle et al, 1999). Therefore, the dorsolateral PFC, as part of the WM system, 
plays a critical role in mediating the control processes required for the active manipulation, 
or selective utilization of items contained in WM. 
Several lines of research raised the possibility of estrogen’s modulating effect on the PFC 
(Joffe et al, 2006). In particular, analysis of human brain specimens has revealed that in PFC 
estradiol concentrations was approximately 2 times higher than in temporal cortex or 7 
times higher than in HF, showing that the PFC is a principal target for estrogen in the adult 
female brain (Bixo et al, 1995). Animal studies reported that estrogen influences the activity 
of several neurotransmitter systems in the PFC. For example, a 56% reduction in ChAT and 
a 24% reduction in high affinity choline uptake in the frontal cortex of female rats at 28 
weeks post-OVX were found; this effect was prevented or reversed in rats treated with ERT 
(Singh et al, 1994) Estrogen may also regulate neurotransmission in the PFC of nonhuman 
primates. Remarkable increases in axons immunoreaction for dopamine ┚-hydroxylase and 
5-HT and reductions in the density of axons immunoreactive for ChAT and tyrosine 
hydroxylase were observed in the dorsolateral PFC of adult rhesus monkeys, following 
OVX (Kritzer & Kohama, 1998, 1999) In OVX monkeys treated with estrogen, the density of 
labeling was similar to hormonally intact controls, suggesting that estrogen plays a role in 
maintaining cholinergic, noradrenergic, serotonergic, and dopaminergic activity in the PFC. 
In addition, in humans, neuroimaging studies using positron emission tomography (PET) 
(Berman et al, 1997) or functional magnetic resonance imaging (fMRI) (Shaywitz  et al, 1999) 
have evidenced systematic differences in patterns of task-induced brain activation in PFC, 
connected to differences in women’s estrogen status (Roberts et al, 1997). A behavioral study 
conducted on rhesus monkeys showed that menopausal and postmenopausal females, 
compared to age-matched but premenopausal females, exhibited an impairment of 
performance on the WM delayed response task, which is commonly used to assess PFC 
dysfunction in nonhuman primates. Taken together, the neuroendocrine and behavioral 
data supply evidence to suggest that estrogen is active in the PFC. In such a case, estrogen 
could modulate cognitive functions mediated by the PFC in women.  
Taking into account that the dorsolateral PFC is one of the areas of the frontal cortex where 
estrogen activity was demonstrated (Maki, 2005), this steroid hormone might contribute to 
WM function by modulating information processing in the PFC (Duff & Hampson, 2000). In 
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order to verify the hypothesis that the WM system is responsive to estrogen in women, Maki 
et al. (Maki, 2005) designed a study evaluating, in a group of postmenopausal women, two 
measures, one verbal and one spatial, which strongly recruit the WM system (Digit 
Ordering, Spatial WM task). Their findings confirmed the hypothesis that estrogen is active 
within PFC and it can influence functions dependent on this region, like WM.  
In agreement with the above findings, evidence exists showing the activation of PFC during 
the performance of WM tasks (Badre D, Wagner, 2007; Petrides et al, 1993) and decrease of 
WM with increasing age (Grady & Craik, 2000) . The integrity of both the PFC and its 
complex neural circuitry, which consolidates input from various modalities via cortical, 
subcortical, and limbic connections, are critical to intact executive functions, an 
amalgamation of cognitive processes that includes WM, besides directed attention, response 
inhibition, dual task coordination, cognitive set switching, and behavioral monitoring. 
Dopaminergic and serotonergic brain stem afferents to PFC (Jakob & Goldman-Rakic, 1998)  
modulate the excitability of prefrontal pyramidal neurons. Experimental reduction of 
prefrontal dopamine in rhesus monkeys and naturally occurring loss of dopaminergic 
neurons in Parkinson's disease are associated with deficits in WM (Gotham et al, 1988). The 
dopaminergic D2 receptor agonist bromocriptine improves WM (Luciana et al, 1991) while 
D2 antagonist raclopride had a minor inhibitory effect (Williams & Goldman-Rakic, 1995). 
Ovarian steroids are powerful modulators of the dopaminergic neurotransmission. In 
monkeys ovariectomy reduces, while subsequent estrogen and progesterone replacement 
restores, the density of axons immunoreactive for tyrosine hydroxylase in the dorsolateral 
PFC (Kritzer & Kohama, 1998) . Ovariectomy also decreases the density of axons 
immunoreactive for ChAT and increases the density of fibers immunoreactive for dopamine 
┚–hydroxylase. ERT alone attenuates these effects (Kritzer & Kohama, 1999) estradiol also 
decreases monoamine oxidase (MAO), involved in the degradation of dopamine (McEwen, 
2002). 
3.1.1.1 Working memory for emotional facial expressions across the menstrual cycle in 
young women. 
Facial expressions represent non-verbal communicative displays that are critical in social 
cognition, allowing quick transmission of valence information to cospecifics concerning 
objects or environments (Blair et al, 1999). In particular, humans and non-human primates 
use facial expressions to communicate their emotional state. This communication can be 
reflexive, as situations may induce emotions that are spontaneously expressed on the face. 
In other cases, particularly in humans, facial expressions may consist in volitional signals 
with the aim of  communicating, and not reflecting, the real emotional state of the subject 
(Ekman, 1993) . Six basic emotions - happiness, sadness, anger, fear, disgust and surprise - 
and their corresponding facial expressions are recognized across different cultures (Ekman 
& Friesen, 1971). Imaging studies showed that different cerebral areas are activated during 
the processing of different, distinct emotions (Blair et al, 1999). It was also reported that not 
only subcortical areas, such as amygdala or basal ganglia, but also cortical areas, mainly 
PFC, cingulate cortex, and temporal cortices, are essential in emotion processing  (Blair et al, 
1999; Northoff et al, 2000). Many studies on emotion perception in faces have been focused 
on the identification of the cerebral regions, whose damage causes emotion perception 
deficits (Adolphs, 2002) . This facial emotion recognition deficit appears to be, at least in 
part, related to a more general problem in cognitive functions including the categorisation, 
discrimination and identification of facial stimuli, as well as deficits in other cognitive 
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processes, such as WM, which are impaired in the psychiatric and neurological damages 
(Addington & Addington, 1998; Kee et al, 1998). 
Physiological fluctuations in ovarian hormones across the menstrual cycle allow for non-
invasive studies of the effects of estrogen on cognition in young women and underlie a 
reliable pattern of cognitive change across the menstrual cycle (Maki et al, 2002).  
The cognitive performance in a WM task for emotional facial expressions, using the six basic 
emotions (Ekman &Friesen, 1971)  as stimuli in the DMTS, was evaluated in young women 
in the different phases of  the menstrual cycle, in order to point out possible differences 
related to the physiological hormonal fluctuations (Gasbarri et al, 2008, 2009). Our findings 
suggest that high levels of estradiol in the follicular phase could have a negative effect on 
delayed matching-to-sample WM task, using stimuli with emotional valence. Moreover, in 
the follicular phase, compared to the menstrual phase, the percent of errors was significantly 
higher for the emotional facial expressions of sadness and disgust (Gasbarri et al, 2008, 2009) 
The evaluation of the response times (time employed to answer) for each facial expression 
with emotional valence showed a significant difference between follicular and luteal in 
reference to the emotional facial expression of sadness (Gasbarri et al, 2008, 2009). Our 
results show that high levels of estradiol in the follicular phase could impair the 
performance of WM. However, this effect is specific to selective facial expressions 
suggesting that, across the phases of the menstrual cycle, in which conception risk is high, 
women could give less importance to the recognition of the emotional facial expressions of 
sadness and disgust. This study is in agreement with research conducted on non-human 
primates, showing that fluctuations of ovarian hormones across the menstrual cycle 
influence a variety of social and cognitive behaviors. For example, female rhesus monkeys 
exhibit heightened interest for males and enhanced agonistic interactions with other females 
during periods of high estrogen level (Lacreuse  et al, 2007). 
Moreover, our data could also represent a useful tool for investigating emotional 
disturbances linked to menstrual cycle phases and menopause in women.  
3.1.1.2 Working memory for emotional facial expressions in capuchin monkeys 
Non-human primates represent important and relevant models for the study of emotional face 
processing, because they share several cognitive and physiological characteristics with 
humans. The behavioral evidence includes similarities in innate action patterns such as body 
movements and communication signals, as well as highly flexible behavioral tactics and clever 
problem-solving strategies (Preuschoft, 2000) . The capuchin monkey (Cebus apella) has been 
the focus of various researches due to its behavioral similarities with apes. Moreover, 
capuchins exhibit a rich repertoire of facial expressions and body postures, which convey an 
array of messages to co-specifics about their internal state (Fragaszy et al, 2004); furthermore, 
they display tool-using capacities, and can readily solve the WM tasks, such as DNMS and 
concurrent discrimination learning task (Resende et al, 2003; Tavares & Tomaz, 2002). 
Capuchin monkeys have well-developed facial musculature mobility, which allows 
considerable expressive variability, and they also have excellent visual acuity for discerning 
signals by others. However, most of the visual signals of capuchin monkeys are 
accompanied by vocalizations and associated context. In general, movement and body 
expression are important to understand emotional valence. 
In a previous study we developed a pool of 384 pictures of capuchin monkey (Cebus apella) 
faces, classified according to emotional valence (positive/ pleasant, negative/unpleasant 
and neutral/indifferent), to examine whether WM can benefit from the emotional content of 
visual stimuli in a delayed non-matching to sample task (DNMTS) (Abreu et al, 2006). 
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Seven adult capuchin monkeys were tested with a computer system and touch screen. 
Geometric figures (control) and the co-specific faces pictures were used as stimuli. The 
subjects obtained a similar performance to positive, negative and neutral pictures. However, 
the monkeys performed above the upper confidence limits around chance to all kinds of 
stimulus showing that they are able to learn the tests using emotional faces. Furthermore, 
the capuchin monkeys had much better performance when using geometric figures 
compared with the co-specific pictures.  
On a whole, our results show that capuchin monkeys were able to perform this new WM 
task, thus indicating the possible usefulness of applying the paradigm utilized in this study 
to investigate emotional memory in non-human primates (Abreu et al, 2006). 
4. Estrogen and the aging brain  
One of the most interesting research fields in women’s health of the last decade includes the 
growing appreciation that estrogen plays relevant neurotrophic and neuroprotective roles 
during adulthood. This amplifies the relevance of  the potential impact of the prolonged 
post-menopausal hypoestrogenic state on learning and memory processes and the potential 
increased vulnerability of ageing women to brain injury and neurodegenerative diseases. 
The longer female life expectancy has implied that nowadays women live one-third of their 
lives beyond ending of their ovarian function, increasing the need for new therapeutic 
strategies to facilitate successful aging (defined as low probability of disease), high cognitive 
and physical abilities, and active engagement in life. Taking into account that changes in the 
ageing nervous system are subtle, they could be reversed  and cognitive performance may 
be  improved by pharmacological treatments. 
The ematic concentration of estrogens decreases with age and the post-menopause low 
values of estrogens are often followed by an acceleration of the age effects on cognition. 
Cognitive decline during aging affect memory abilities, attention, and speed of information 
processing (Sherwin & Henry, 2008). 
Even though several cognitive functions seem to be unaltered in normal aging, age-related 
impairments are mainly evident in tasks implying free or cued recall or WM (Small et al, 
1999). Although verbal memory has been reported to be the cognitive function most deeply 
affected with increasing age (Marquis et al, 2002; Rabbitt & Lowe, 2000) other cognitive 
domains such as attention (Stankov, 1988) visual perception, and verbal fluency (Ashman, 
1999)  are also influenced. Thus, the attempt to delay or prevent the cognitive impairment 
occurring with normal aging is an important goal to protect the quality of life for women 
during the latter one third of their lifespan. Because ERs are present in both the HF and 
frontal lobes which subserve verbal memory, WM and retrieval, we can hypothesize that 
estrogen might play an important protective role against the decline in these cognitive 
functions, occurring with normal aging. Therefore, researchers have tried to verify if the 
estrogen administration to women at the beginning or during  menopause would protect 
against cognitive impairments that normally take place with increasing age. 
During the past few decades, data from basic neuroscience and from animal and human 
studies have suggested that ERT given to postmenopausal women might protect against 
specific cognitive declines occurring with normal aging. On the other hand, the numerous 
inconsistencies in this body of evidence point to the possibility that there are contingencies 
which modify the supposed neuroprotective effects of ERT on cognitive aging (Sherwin & 
Henry, 2008).  
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Even though an extensive literature on the putative neuroprotective effects of estrogen on 
cognitive functions in postmenopausal women is available, many discrepancies still exist. 
The critical period hypothesis, introduced many years ago, attempts to account for the 
inconsistencies in this literature by positing that ERT can have a protective effect on some 
aspects of cognition in older women, only when it is initiated soon after the menopause. 
Indeed, data from basic neuroscience and from the animal and human studies provides 
compelling support for the critical period hypothesis (Sherwin & Henry, 2008). Although it 
is not completely clarified why estrogen does not protect cognitive functions and may even 
cause harm when administered to women over the age of 65 years, it is possible that the 
typical modifications of brain aging, such as a reduction of brain volume, neuronal size, 
number of dendritic spines, and alterations in neurotransmitter systems form an adverse 
background preventing the neuroprotective effects of exogenous estrogen.  Other factors 
that have likely contributed to the inconsistencies of the estrogen–cognition literature 
include differences in the estrogen agonist utilized, their route of administration, cyclic 
versus continuous regimens, and the concomitant administration of progestins. In 
conclusion, there is considerable evidence supporting the use of estrogen during the 
menopause and postmenopausal periods for the prevention and treatment of AD and other 
neurologic disorders. Nevertheless, the efficacy of estrogen requires that we take into 
account the most recent data on hormone neurobiology, in order to administer the hormone 
at the right time, with the right formulation, and to the appropriate population of women 
(Gleason, 2005; Simpkins & Meharvan, 2008). 
5. Conclusions  
Besides the mechanisms concerning the neuroprotective role of estrogen in dependence of 
the age of its administration, further studies are necessary to completely clarify the relative 
efficacy of cyclic versus continuous hormone regimens, the accessibility to the brain of 
various estrogen compounds, and their different routes of administration. Moreover, there 
are no dose response results related to estrogen and cognitive functioning in women, in 
spite of the increasing clinical trend for administering low doses of estrogen to 
postmenopausal women. The finding of a prominent dose-dependent effect of  estradiol on 
the density of hippocampal CA1 pyramidal spine synapse in OVX rats (MacLusky et al, 
2005) emphasizes the relevance of obtaining such data for women. When the optimal 
neurobiological and pharmacological parameters of the estrogen–cognition relationship are 
known, these data could be used clinically to attenuate or to prevent cognitive decline in 
older women, which represent the fastest growing section of the population in 
industrialized countries. 
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